Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,986,913
+$1,986,913 QoQ
Shares Held
1,097,742
Ownership
0.324%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Derivatives in OCGN
reported options exposure · as of Sep 30, 2021CallValue
$629,686
CallShares
87,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $501,603,270 across 143 Biotechnology names. OCGN ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
472,961 | $52,664,207 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
438,595 | $42,653,363 | |
| 3 | EXEL |
Exelixis, Inc.
|
803,866 | $34,477,812 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
522,019 | $30,334,524 | |
| 5 | MLYS |
Mineralys Therapeutics, Inc.
|
1,001,728 | $27,136,811 | |
| 6 | CGEM |
Cullinan Therapeutics, Inc.
|
1,112,803 | $15,812,930 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
270,412 | $15,724,457 | |
| 8 | KOD |
Kodiak Sciences Inc.
|
328,670 | $12,528,900 |
All Filings in OCGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,986,913 | 1,097,742 | Shares | Other | 2026-05-15 | |
| 2021-09-30 | $629,686 | 87,700 | Call | Other | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||